Skin Test Spots Heart Risks in Healthy People

By Ed Edelson
HealthDay Reporter
Friday, April 18, 2008; 4:00 AM

Copyright © 2008 ScoutNews, LLC. All rights reserved.

THURSDAY, April 17 (HealthDay News) -- A cholesterol test that requires no more than a small sample of skin cells scraped off the palm of the hand can measure the risk of heart disease in healthy people, researchers report.

The test looks at levels of skin sterol, a molecular relative of blood cholesterol.

In a test on 9,055 people, skin sterol readings correlated closely with levels of good HDL cholesterol and of C-reactive protein, a marker of inflammation that is a risk factor for cardiovascular disease. Dr. Dennis L. Sprecher was expected to report on the findings Thursday at the American Heart Association Conference on Arteriosclerosis, Thrombosis and Vascular Biology in Atlanta.

The test described at the meeting is a new version of an existing skin sterol test now being used in Europe and in Canada and on a limited basis in the United States, said Michael Evelegh, executive vice president of clinical and regulatory affairs with PreMD Inc., a Canadian company that markets the older test and is developing the newer one.

"What happens with this test is that a little plastic device is applied to the surface of the palm of the hand to peel off a layer of dead skin cells," Evelegh said. "The sample is sent to a laboratory, which measures the cholesterol in those cells. It turns out that cholesterol in the skin is associated with the risk of cardiovascular disease."

In 2005, Dr. James H. Stein, of the University of Wisconsin, reported a study in which cholesterol readings of the older test correlated with ultrasound measurements of thickening and narrowing of arterial walls.

Stein said through a university spokesman that he was not free to comment on the test, because he is providing information to the U.S. Food and Drug Administration on its possible wider use.

Similar ultrasound measurements have not been done with the newer test, Evelegh said. "We have just started to generate clinical data," he said.

The older test provided on-the-spot cholesterol readings, while the new one requires samples to be sent to a laboratory for analysis.